Work

SA-4-1BBL as the immunomodulatory component of a HPV-16 E7 protein based vaccine shows robust therapeutic efficacy in a mouse cervical cancer model

Year: 2010

Type: article

Source: Vaccine

DOI: 10.1016/j.vaccine.2010.06.073

Authors: Rajesh K. Sharma, Abhishek K. Srivastava, Esma S. Yolcu, Kathryn J. MacLeod, Rich-Henry Schabowsky, Shravan Madireddi, Haval Shirwan

Institutions: University of Louisville, ApoVax (United States)

Language: English

Topic: Immunotherapy and Immune Responses

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: green

Funders: National Cancer Institute, National Institute of Allergy and Infectious Diseases

Awards: ApoVax104-HPV as a Novel Vaccine for Cervical Cancer, ApoVax-SVN as a Novel Vaccine for Cancer Immunotherapy, ApoVax104-TB as a Novel Vaccine for Tuberculosis

OpenAlex ID: W2002108471

FWCI: 1.786

Cites: 45

Cited by: 39

Related to: 10